A Study of LY3209590 in Participants With Type 1 Diabetes

Clinical trial NCT04450407 · COMPLETED

Trial details

NCT number: NCT04450407
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2020-07-06
Primary completion: 2021-10-01
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.